ACE2 |
Angiotensin-converting enzyme 2 |
ARBs |
Angiotensin receptor blockers |
ALI |
Acute lung injury |
AT1R |
Angiotensin type 1 receptor |
AT2R |
Angiotensin 2 receptor |
ACEI |
Angiotensin-converting enzyme inhibitor |
Ang II |
Angiotensin II |
COVID-19 |
Coronavirus disease |
cGAS |
Cyclic guanosine phosphate adenosine phosphate synthase |
cGAMP |
Cyclic guanosine monophosphate adenosine monophosphate |
DCs |
Dendritic cells |
IRF3 |
Interferon regulatory factor 3 |
MDA5 |
Melanoma differentiation associated gene 5 |
MAVS |
Mitochondrial antiviral-signaling protein |
MasR |
Mas receptor |
MyD88 |
Myeloid cell differentiation factor 88 |
NLRs |
Nucleotide-binding oligomerization domain-like receptors |
NLRP3 |
NOD-like receptor family pyrin domain containing 3 |
PRRs |
Pattern recognition receptors |
RAS |
Renin-angiotensin system |
rhACE2 |
Recombinant human angiotensin converting enzyme 2 |
RIG-I |
Retinoic acid-inducible gene I |
SARS-CoV-2 |
Severe Acute Respiratory Syndrome Coronavirus 2 |
STING |
Stimulator of interferon genes |
TLRs |
Toll-like receptors |